Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
injection pen
MedTech
BD dubs diabetes spinoff embecta and finalizes leadership
Embecta is set to launch as its own brand in 2022 after almost a century of supplying insulin pens and syringe under BD's banner.
Conor Hale
Dec 6, 2021 10:59am
FDA clears Bigfoot’s dose-recommending smart insulin pens
May 11, 2021 12:02pm
Roche, Biocorp launch digital insulin pen add-on in France
Apr 13, 2021 11:58am
Teva launches generic EpiPen in the U.S.
Nov 28, 2018 10:15am
FDA approves first generic EpiPen autoinjector
Aug 16, 2018 4:31pm
Pfizer contracts with Antares for a new rescue auto-injector
Aug 6, 2018 10:16am
